Home » Topics » Regulatory

Regulatory
RSS

Seroquel deemed approvable by the FDA

Nov. 3, 2003

Risperdal Consta receives FDA approval

Nov. 3, 2003

Synagis approved for expanded use in Europe

Nov. 3, 2003

Canadian approval for Gleevec for newly diagnosed Ph+ CML

Oct. 30, 2003

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

Levaquin approved for five-day treatment of CAP

Oct. 30, 2003

Cyberonics submits PMA-S for VNS Therapy

Oct. 29, 2003

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Starlix approved in combination with TZD for type 2 diabetes

Oct. 27, 2003

Approvable letter issued for Foradil Certihaler

Oct. 24, 2003